BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/78/0.1/21.06.24 | Real-time Boerse Frankfurt Warrants 11:02:49 2024-06-13 EDT | ||
| 0.89 EUR | -4.30% |
|
| Current month | +13.41% | ||
| 1 month | +1.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.89 | -4.30% |
| 24-06-12 | 0.93 | +5.68% |
| 24-06-11 | 0.88 | +12.82% |
| 24-06-10 | 0.78 | -15.22% |
| 24-06-07 | 0.92 | -2.13% |
Real-time Boerse Frankfurt Warrants
Last update June 13, 2024 at 11:02 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM575G |
| ISIN | DE000VM575G8 |
| Date issued | 2023-11-30 |
| Strike | 78 $ |
| Maturity | 2024-06-21 (8 Days) |
| Parity | 10 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.8 € |
|---|---|
| Lowest since issue | 0.28 € |
| Spread | 0.01 € |
| Spread % | 1.10% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.77
USD
Average target price
96.31
USD
Spread / Average Target
+9.73%
- Stock Market
- Warrants
- Warrant
